Archives: Speakers

Jim Kremidas is currently the Executive Director for ACRP, a not-for profit association the represents the clinical research enterprise. Prior to that he conducted consulting services for a variety of clients including support for investigator sites, academic institutions, sponsors and sup-pliers. He was the SVP of Patient Recruitment at two different large CROs for over 6 years where he and his team were responsible for de-veloping and implementing patient enrollment strategies for global clin-ical trials. Prior to that, he spent 24 years with Eli Lilly and Company. From 1999 to 2008 he led their clinical trial patient recruitment and re-tention efforts. In this role, he focused on predicting and accelerating the enrollment rates for all corporate studies. While in Strategic Sourc-ing he was responsible for the outsourcing of clinical development pro-jects to strategic suppliers including CRO’s, scientific staffing firms and Patient Recruitment Suppliers. Before his assignment in clinical devel-opment strategic sourcing, Mr. Kremidas led Lilly’s efforts to select and establish relationships with direct to consumer and professional adver-tising agencies, as well as, implement standardized processes for the de-velopment and implementation of marketing materials.

He is on the advisory board of CISCRP (a non-profit organization fo-cused on enhancing patient participation in clinical trials) and is also a volunteer for the Clinical Trial Transformation Initiative (CTTI) with Duke and the FDA. He is a frequent presenter at Industry Conferences and his articles/papers have been published in a wide variety of trade journals

Michael Causey is Editor-in-Chief at the Association of Clinical Research Professionals, where he oversees the peer-review journal, Clinical Researcher, and a weekly news publi-cation, CRbeat. He also hosts the “Spotlight On…” series on ACRPtv. Previously, he was a journalist and Editorial Director at FDAnews, where he ran the newsroom.

International banker with over 25 years in senior management in Private Banking with Merrill Lynch & Co., Deutsche Bank AG, CA Indosuez, Credit Suisse, Julius Bär and worked in New York, London. Tokyo, Mumbai, Zürich.

• – Former Country Head Deutsche Bank AG, India, Private Banking & Investments.
• – Former CEO, International College of Financial Planning, India.
• – Attended World Economic Forum (WEF) Davos Switzerland, 2015, 2016.

Areas of expertise:

• FinTech, Private equity,  Asset Allocation Specialist, Impact & ESG Investing

Beate Born is currently Head of Strategic Projects at UBS Wealth Management in Zürich. She runs global regulatory initiatives (e.g. MiFIDII implementation), large platform projects and ad hoc responses to geopolitical events (e.g. Brexit). With 17 years of experience in operational risk, change and regulatory management in financial services in Europe, Asia and Australia she recently set a professional and academic focus on sustainability and data in banking.

Beate is a member of the EDM council’s ESG committee and active within the Women in Data network, she is frequently appears as a guest speaker at industry conferences and has written papers amongst other topics on ‘Regulatory Equivalence’, Client Advisor Barriers to Sustainable Investing’ and ‘Operational Risk Management during the Covid-19 Crisis’.

Beate has completed Master’s degrees at the Sorbonne and at the Clark University Business School of Management  as well as an Executive Degree at the Swiss Finance Institute. She is certified in Financial Market Regulation by the University of Zürich and is currently obtaining a Master’s degree at the University of Cambridge Institute for Sustainability Leadership.